Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.470
+0.014 (2.98%)
Nov 21, 2024, 4:00 PM EST - Market closed
Turnstone Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 11 | 59 | - | - |
| Enterprise Value | -33 | -47 | - | - |
| Last Close Price | 0.46 | 2.54 | - | - |
| PS Ratio | - | 3.04 | - | - |
| PB Ratio | 0.24 | 0.60 | - | - |
| P/TBV Ratio | 0.30 | 0.60 | - | - |
| Debt / Equity Ratio | 0.04 | 0.03 | 0.07 | 0.03 |
| Debt / EBITDA Ratio | - | - | - | 0.07 |
| Asset Turnover | - | 0.17 | 0.49 | - |
| Quick Ratio | 3.32 | 7.93 | 2.61 | 3.05 |
| Current Ratio | 3.75 | 8.57 | 2.81 | 3.23 |
| Return on Equity (ROE) | -94.47% | -65.27% | -38.45% | - |
| Return on Assets (ROA) | -52.52% | -32.34% | -10.18% | - |
| Return on Capital (ROIC) | -61.18% | -41.49% | -18.28% | - |
| Earnings Yield | -667.52% | -93.92% | - | - |
| FCF Yield | -598.44% | -114.68% | - | - |
| Buyback Yield / Dilution | -259.20% | -365.39% | 7.96% | - |
| Total Shareholder Return | -259.20% | -365.39% | 7.96% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.